Insulin resistance in type 1 diabetes

Area of Science:

• Endocrinology
• Metabolic Diseases
• Immunology

Background:

• Insulin resistance is a critical, yet often underestimated, factor in type 1 diabetes pathogenesis.
• Conditions like puberty and antecedent illnesses can exacerbate insulin resistance, contributing to hyperglycemia in type 1 diabetes.
• The 'honeymoon period' in type 1 diabetes may represent a transient improvement in insulin sensitivity.

Purpose of the Study:

• To highlight the significant role of insulin resistance in type 1 diabetes.
• To re-evaluate the interpretation of insulin secretion data in light of insulin sensitivity.
• To explore potential benefits of targeting insulin resistance in type 1 diabetes management.

Main Methods:

• Review of existing literature on insulin resistance and type 1 diabetes.
• Analysis of the physiological interplay between beta-cell function and insulin sensitivity.
• Discussion of methodological considerations for intervention trials.

Main Results:

• Insulin resistance is a key driver of hyperglycemia in type 1 diabetes.
• Intensive diabetes management can improve both insulin sensitivity and beta-cell function.
• Current interpretation of insulin secretion data may be confounded by concurrent changes in insulin sensitivity.

Conclusions:

• Insulin resistance is a major contributor to type 1 diabetes progression and clinical presentation.
• Formal assessment of insulin sensitivity is crucial in type 1 diabetes intervention trials.
• Treatments targeting insulin resistance could be beneficial for specific patient subsets with type 1 diabetes.